Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 15
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
16 to 75
Other
CGC05MK1002
NCT00188149
Last Modified:
4/29/2008
 
First Published:
11/1/2002
2.
Phase III Randomized Study of Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone (BEACOPP) Versus Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD) in Patients With Stage III or IV Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
16 to 60
Other
EORTC-20012
GELA-EORTC-20012, BNLI-EORTC-20012, GELCAB-EORTC-20012, NORDICLG-EORTC-20012, CAN-NCIC-EORTC-20012, ALLG-HD04, NCT00049595
Last Modified:
1/23/2007
 
First Published:
11/24/2002
3.
Phase III Randomized Study of Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Patients With Recurrent Malignant Glioma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Other
MRC-BR12
EU-20114, ISRCTN83176944, NCT00052455
First Published:
2/5/2007
4.
Phase III Randomized Study of Early Fludeoxglucose F 18 Positron Emission Tomography Scan-Guided Treatment Adaptation Versus Standard Combined Modality Treatment in Patients With Previously Untreated Supradiaphragmatic Stage I or II Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
15 to 70
Other
EORTC-20051
GELA-H10, EUDRACT-2005-002765-37, NCT00433433
Last Modified:
6/19/2008
 
First Published:
2/5/2007
5.
Phase III Randomized Study of Combination Chemotherapy in Pediatric Patients With Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Diagnostic, Treatment
Active
Under 18
Other
EURONET-PHL-C1
EU-20703, EUDRACT-2006-000995-33, NCT00433459, CCLG-HD-2007-10
6.
HD18 for Advanced Stages in Hodgkins Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 to 60
Other
HD18
NCT00515554
Last Modified:
9/30/2008
 
First Published:
5/8/2008
7.
Phase III Randomized Study of Response-Adapted Therapy Using Fludeoxyglucose F 18-PET/CT Imaging in Patients With Newly Diagnosed Stage II-IV Hodgkin Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Other
CRUK-2007-006064-30
2007-006064-30, CRUK-07/146, NCT00678327
Last Modified:
4/24/2008
 
First Published:
2/20/2004
8.
Phase II Study of Vinblastine, Cyclophosphamide, Procarbazine, Prednisolone, Etoposide, Mitoxantrone, and Bleomycin in Older Patients With Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
Over 60
Other
UON-SHIELD
EU-20346, NCT00079105
9.
Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
Over 18
Other
0904-473
NCT00151281
Last Modified:
10/12/2008
 
First Published:
5/23/2006
10.
Phase II Study of Rituximab in Combination With Standard Chemotherapy Comprising Methotrexate, Vincristine, Procarbazine Hydrochloride, and Cytarabine in Patients With Primary Central Nervous System Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
NCI
ECOG-E1F05
E1F05, NCT00335140
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute